Retinopathy is a major complication of diabetes mellitus and a leading cause of blindness. Treatment modalities for restoring retinal function are relatively ineffective. Although proper retinal function relies on a sufficient supply of blood flo and alterations of both neural and vascular retina have been reported, the mechanism and temporal relationship between neural retina damage and vasomotor function remains unclear. Therefore, simultaneous assessment and unveiling the mechanism of vascular and neural changes in the retina during early diabetes is vital to our understanding of the retinal pathogenesis as well as to development of new therapies for early treatment. Although oxidative stress is implicated in retinal damage in diabetic retinopathy, clinical therapy with antioxidants has been mostly ineffective, suggesting other mechanisms may be involved in sustaining vasomotor and neural retina dysfunction. Also, development of an animal model of diabetes relevant to the human retinal microcirculation and its pathophysiology is lacking. To address these clinically important issues, we have developed a streptozocin-induced type 1 diabetes model in the pig, an animal model that we have shown to resemble the human in retinal vasomotor regulation and dysregulation. Our preliminary data show that within 2 wk of diabetes, endothelium-dependent nitric oxide (NO)-mediated dilation of retinal arterioles is impaired. Elevation of superoxide within diabetic retinal arterioles was observed but antioxidants did not improve endothelium-dependent dilation. Vasomotor impairment was improved by blockade of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), proteasomes or phosphorylation of c-Jun N- terminal kinase-1 (JNK1). LOX-1 and JNK1 are implicated in cardiovascular diseases possibly by altering endothelial NO synthase activity, but their signaling associated with retinal vascular disease remains unknown. Since scotopic b-wave amplitude is also reduced during 6-wk but not 2-wk diabetes, it appears vasomotor dysfunction precedes inner neural retina damage. Thus, the goal of this study is to delineate the link between LOX-1 and JNK1 in the retinal endothelial dysfunction and to determine whether these two molecules can serve as novel targets for improving retinal arteriolar function, along with secondary amelioration of neural retina function, during early diabetes. We will test the hypothesis that early diabetes initiates superoxide-dependent upregulation of LOX-1 and subsequent downstream JNK1/ubiquitin-proteasome signaling for sustained degradation of SIRT1 in the retinal arteriolar endothelium, which leads to reduction of NO-mediated dilation prior to neural retina dysfunction. We will pursue two specific aims: (1) Determine the contributions of superoxide and LOX-1 to diabetes-induced endothelial dysfunction of retinal arterioles prior to neural retina damage; (2) Delineate the contribution of JNK1-dependent phosphorylation and ubiquitin-proteasome degradation of SIRT1 to diabetes-induced endothelial dysfunction of retinal arterioles. Outcomes from basic findings will be translated to therapeutic treatment of retinal vascular disease via siRNA technology in early diabetes.

Public Health Relevance

Alteration in nutritional blood flow to the retina in the eye and damage to the neural cells during diabetes are regarded as key events leading to visual impairment and blindness. Experimental and clinical evidence suggests that high blood sugar levels damage the small blood vessels, the arterioles, in the retina leading to insufficient supply of oxygen and nutrients to the neural cells for proper visual function. Because effective therapies are lacking to treat vascular and neural damage in the retina during the initial stages of diabetes, the goal of this proposal is to identify novel destructive proteins in retinal arterioes that can targeted for therapy during early diabetes to improve both vascular and neural function.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY024624-01A1
Application #
8888305
Study Section
Special Emphasis Panel (DPVS)
Program Officer
Shen, Grace L
Project Start
2015-09-30
Project End
2018-08-31
Budget Start
2015-09-30
Budget End
2016-08-31
Support Year
1
Fiscal Year
2015
Total Cost
$462,420
Indirect Cost
$147,909
Name
Texas A&M University
Department
Surgery
Type
Schools of Medicine
DUNS #
835607441
City
College Station
State
TX
Country
United States
Zip Code
77845
Xie, Wankun; Zhao, Min; Tsai, Shu-Huai et al. (2018) Correlation of spectral domain optical coherence tomography with histology and electron microscopy in the porcine retina. Exp Eye Res 177:181-190
Tsai, Shu-Huai; Xie, Wankun; Zhao, Min et al. (2018) Alterations of Ocular Hemodynamics Impair Ophthalmic Vascular and Neuroretinal Function. Am J Pathol 188:818-827
Xie, Wankun; Zhao, Min; Tsai, Shu-Huai et al. (2018) Data on SD-OCT image acquisition, ultrastructural features, and horizontal tissue shrinkage in the porcine retina. Data Brief 21:1019-1025
Zhao, Min; Xie, Wankun; Tsai, Shu-Huai et al. (2018) Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization. Invest Ophthalmol Vis Sci 59:1125-1133
Chen, Yen-Lin; Ren, Yi; Xu, Wenjuan et al. (2018) Constriction of Retinal Venules to Endothelin-1: Obligatory Roles of ETA Receptors, Extracellular Calcium Entry, and Rho Kinase. Invest Ophthalmol Vis Sci 59:5167-5175
Hein, Travis W; Xu, Wenjuan; Xu, Xin et al. (2016) Acute and Chronic Hyperglycemia Elicit JIP1/JNK-Mediated Endothelial Vasodilator Dysfunction of Retinal Arterioles. Invest Ophthalmol Vis Sci 57:4333-40